The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease

Eur Respir J. 2015 Apr;45(4):1177-9. doi: 10.1183/09031936.00169114. Epub 2015 Jan 22.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects*
  • Child
  • Child, Preschool
  • Cohort Studies
  • Confidence Intervals
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Tolerance*
  • Female
  • Follow-Up Studies
  • Humans
  • Kaplan-Meier Estimate
  • Linezolid / administration & dosage
  • Linezolid / adverse effects*
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / diagnosis
  • Mycobacterium Infections, Nontuberculous / drug therapy*
  • Nontuberculous Mycobacteria / drug effects*
  • Nontuberculous Mycobacteria / isolation & purification
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Linezolid